Vice President, Drug Substance

The Vice President, Drug Substance leads enterprise drug substance strategy and execution across BioCryst’s small-molecule and biologics portfolio, providing end-to-end leadership for process development, scale-up, manufacturing readiness, and commercialization. This senior role shapes the function’s strategy, organizational capabilities, and technology roadmap while partnering with cross-functional teams and external manufacturing partners. The position ensures phase-appropriate, compliant, and commercially viable drug substance processes are advanced in alignment with global regulatory expectations.